German Public Health Insurance Posts €2.6 Billion Surplus in First Half of 2026, But Underlying Deficit Persists as Hospital Costs Surge 9.3 Percent

Germany's network of 93 statutory health insurance funds reported a combined surplus of €2.6 billion during the first six months of 2026, a figure that on the surface might suggest the system is back on solid financial footing.

But officials and analysts warn that the positive balance sheet masks a deeper structural problem: spending is rising far faster than the contributions that fund the system, and the surplus exists only because insurers raised premiums at the start of the year to rebuild reserves that were nearly wiped out in 2024 and 2025.

At the end of June, the funds held approximately €7.5 billion in financial reserves, which translates to just 0.2 months of expenditure and brings them back to the minimum level required by law.

The Numbers Behind the Headline

Total revenue across all statutory funds reached €188.9 billion in the first half of the year, while expenditures came to €186.3 billion. That €2.6 billion gap looks healthy until you examine the growth rates: spending on benefits and administrative costs climbed 7.1 percent compared with the same period in 2025, while contribution income, excluding the supplementary premiums that funds can set individually, rose by just 4.1 percent.

The average supplementary contribution rate that funds charged members stood at 3.13 percent as of the end of June, notably higher than the 2.9 percent benchmark that the Federal Ministry of Health had projected in October 2025 as sufficient to cover 2026 expenses. Many insurers found themselves in a position where they had to charge more than what current spending alone would justify, simply to replenish reserves that had been severely depleted over the previous two years.

The Health Fund's Own Deficit

The central Health Fund, which acts as a clearinghouse that collects contributions and distributes them to individual sickness funds, recorded a deficit of €5.9 billion during the same period. The fund had started the year with a liquidity reserve of approximately 7.1 billion euros as of January 15, 2026, meaning it has now burned through most of that cushion.

Hospital Care Drives the Spending Surge

The single biggest driver of the spending increase was inpatient hospital treatment, where expenditures jumped 9.3 percent, or €5.1 billion, compared with the first half of 2025. That rate of growth is more than double the average annual increase recorded between 2013 and 2024 and slightly exceeds even the record pace set in 2025.

Part of this spike reflects a temporary policy measure. Between November 2025 and October 2026, hospitals are receiving a surcharge equal to 3.25 percent of their invoice amounts to help finance immediate transformation costs associated with ongoing healthcare reforms. To offset this additional burden on the insurance system, the federal government has committed €4 billion in extra funding to the Health Fund, of which €1.64 billion was already disbursed to hospitals in the first half of 2026, compared with roughly €483 million paid out during the same period a year earlier.

Even after adjusting for this surcharge effect and taking into account new limits on increases in state base case values and budgets for psychiatric and psychosomatic hospitals, which were enacted at the end of 2025, hospital sector spending still grew by 6.3 percent compared with the first half of 2025. That remains significantly above both the long-term average and the rate of growth in contribution-based revenues, pointing to a structurally accelerated spending dynamic that shows no sign of easing.

Between 2013 and 2022, average annual spending growth across the statutory system hovered around 3.5 percent. In the years since, that figure has more than doubled to an average of 8.2 percent per year, a pace that is simply unsustainable given the modest wage and salary increases that form the basis of the contribution system.

Pharmaceuticals and Outpatient Care Also Outpacing Revenue

Spending on prescription drugs rose by 5.1 percent, or €1.5 billion, in the first half of 2026, a rate that slightly exceeds the full-year growth recorded in 2025 of 5.7 percent. Within this category, one sub-segment stood out: pharmaceuticals dispensed in the context of outpatient specialist care saw expenditures surge by 26.7 percent, or €462 million, far outstripping growth in any other area of the drug budget.

Expenditure on outpatient medical treatments grew by 6.0 percent, or €1.63 billion, somewhat less aggressively than in the previous two years but still well above the long-term average and the 4.1 percent increase in contribution revenues. Several factors are at play here. A 2.80 percent increase in the nationwide reference point value, which determines how much physicians are paid per service, contributed to the rise, as did various special payments tied to policy initiatives such as populating the electronic patient record.

Certain sub-categories within outpatient care showed particularly sharp increases. Spending on outpatient specialist treatment jumped 19.7 percent, or €65 million. Specialized outpatient palliative care grew by 18.7 percent, or €88 million. Care delivered within the framework of primary care physician-centered care models increased by 13.1 percent, or €160 million.

Officials caution that these figures should be interpreted with some care, as billing data for the first half of the year is only available to a limited extent and some of the reported growth reflects estimates and projections that will be refined as more complete data becomes available.

Labor-Intensive Services Continue to Strain the System

Two areas that rely heavily on human labor continue to show growth rates that far exceed what the contribution system can support. Medical treatment care, which encompasses nursing services provided in connection with medical treatments, grew by 10.5 percent, or €0.6 billion, in the first half of 2026. This sector has now outpaced both total statutory health insurance spending and contribution-based revenue growth every single year since 2013.

Therapeutic services, which include occupational therapy and physiotherapy, recorded growth of 9.9 percent, or €709 million, continuing a trend that has held in all but two years (2017 and 2020) over the past decade. A significant portion of this increase, €443 million, came from therapeutic services delivered under an expanded provider responsibility model, often referred to as blank prescriptions, where therapists have greater autonomy in determining the course of treatment. Some of this growth represents a shift from the older therapeutic services model to this newer form of care rather than purely additional volume, but even accounting for that, the underlying trend remains one of sustained above-average expansion.

Other Areas of Concern

Preventive and rehabilitative care, which had seen average annual growth of around 10.4 percent in the years following the pandemic-related disruptions of 2020, showed a more moderate increase of 5.9 percent, or €153 million, in the first half of 2026 compared with the first quarter. While that represents a slowdown from the 9.0 percent growth recorded in the first quarter, it still exceeds the rate of increase in contribution revenues and continues to contribute to the widening structural funding gap.

Expenditure on travel costs, primarily ambulance journeys and other medically necessary transportation, grew by 8.1 percent, or €420 million, with ambulance services alone up 11.7 percent, or €95 million.

Vaccinations saw spending rise by 8.5 percent, or €143 million. Sick pay, which covers wage replacement for employees unable to work due to illness, increased by 7.4 percent, or €798 million. Dental treatments excluding dentures grew by 5.9 percent, or €438 million. Medical aids and devices, such as wheelchairs, hearing aids, and compression stockings, saw expenditures rise by 4.4 percent, or €268 million.

In virtually every major category, the growth rate exceeds the 4.1 percent increase in contribution-based income, underscoring a system-wide dynamic where spending is simply outpacing the revenue base.

Administrative Costs Remain Relatively Contained

In contrast to benefit expenditures, administrative costs have developed much more moderately. Material administrative costs, which cover things like office supplies, IT systems, and facility expenses, actually declined by 2.2 percent, or €57 million, in the first half of 2026. Personnel administrative costs, which include salaries for claims processors, customer service representatives, and other back-office staff, rose by 3.8 percent, or €216 million.

Wage and salary increases, which form the basis of the contribution system, have not kept pace with healthcare cost inflation. Between 2013 and 2022, average annual spending growth was around 3.5 percent, a rate that was broadly sustainable given wage trends at the time. Since then, that figure has more than doubled to 8.2 percent per year, while contribution revenues have grown at a much more modest 4 to 5 percent annually.

The result is a structural funding gap that widens with each passing year, forcing funds to either draw down reserves, borrow from the Health Fund, or request additional federal support.

The €2.6 billion surplus reported for the first half of 2026 should be understood in this context: it is not a sign of financial health, but rather a temporary artifact of premium increases designed to rebuild reserves to the legally mandated minimum.